Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Davidson

Showing results (1501-1510 of 1,597) with videos related to

Pageof 160
Sort By:
The American Journal of Cardiology|March 1, 1997
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon PumpJ D Talley, E M Ohman, D B Mark, et al.
Pediatric Research|December 2, 2025
Comparison of volume and non-volume ventilation modes on carbon dioxide following neonatal transportAndrew Leslie, Sarah L Davidson, Beverley Forshaw, et al.
Thrombosis Journal|September 24, 2013
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesMartin H Prins, Anthonie Wa Lensing, Rupert Bauersachs, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
BMC Geriatrics|February 26, 2024
Assessing frailty amongst older people admitted to hospital in a low-income setting: a multicentre study in northern TanzaniaSean L Davidson, Luke Emmence, Sara May Motraghi-Nobes, et al.
Immunity|June 10, 1998
SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte developmentW Swat, K Fujikawa, S Ganiatsas, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2008
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAiJodi L McBride, Ryan L Boudreau, Scott Q Harper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2013
Toward RNAi therapy for the polyglutamine disease Machado-Joseph diseaseMaria do Carmo Costa, Katiuska Luna-Cancalon, Svetlana Fischer, et al.
The New England Journal of Medicine|October 31, 2003
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismH R Büller, B L Davidson, H Decousus, et al.
Science Translational Medicine|May 14, 2025
An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and miceLuis Tecedor, Yong Hong Chen, David E Leib, et al.
Pageof 160

Showing results (1501-1510 of 1,597) with videos related to

Sort By:
Pageof 160
The American Journal of Cardiology|March 1, 1997
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon PumpJ D Talley, E M Ohman, D B Mark, et al.
Pediatric Research|December 2, 2025
Comparison of volume and non-volume ventilation modes on carbon dioxide following neonatal transportAndrew Leslie, Sarah L Davidson, Beverley Forshaw, et al.
Thrombosis Journal|September 24, 2013
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesMartin H Prins, Anthonie Wa Lensing, Rupert Bauersachs, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
BMC Geriatrics|February 26, 2024
Assessing frailty amongst older people admitted to hospital in a low-income setting: a multicentre study in northern TanzaniaSean L Davidson, Luke Emmence, Sara May Motraghi-Nobes, et al.
Immunity|June 10, 1998
SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte developmentW Swat, K Fujikawa, S Ganiatsas, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2008
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAiJodi L McBride, Ryan L Boudreau, Scott Q Harper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2013
Toward RNAi therapy for the polyglutamine disease Machado-Joseph diseaseMaria do Carmo Costa, Katiuska Luna-Cancalon, Svetlana Fischer, et al.
The New England Journal of Medicine|October 31, 2003
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismH R Büller, B L Davidson, H Decousus, et al.
Science Translational Medicine|May 14, 2025
An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and miceLuis Tecedor, Yong Hong Chen, David E Leib, et al.
Pageof 160